Three Year Outcome of the Phase Iii Clinical Trials With Daclizumab.
Year: 2000
Type: conference-abstract
Source: Transplantation
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2319277693
